Nematode Obesity Model
InquiryOverview
Nematode, as a non-mammal obesity model, has become an important In Vivo Experimental Model in life sciences, due to the advantages of small size, short life cycle, rapid reproduction, easy handling, complete genetic information, highly conserved genes with human diseases, and convenient gene manipulation. Protheragen provides preclinical studies of anti-obesity therapeutics to clients worldwide.
Exploring the Story of Obesity with Our Nematode Model
Nematode Obesity Model Generation
Diet-induced obesity: Our company focuses on inducing nematode obesity through high-cholesterol diets and high-sugar diets. Our researchers have induced the generation of nematode obesity models by adding cholesterol or sugar to the nematode culture medium.
Gene engineering: Nematodes are easily manipulated by genetic tools. Our researchers use gene editing and genome-scale RNA interference (RNAi) to modify specific genes to model nematode obesity. For example, nematodes with mutations in the daf-2 gene have increased fat accumulation and promote glycogen production. daf-16 gene is at the center of the regulation of multiple signaling pathways, is regulated by a variety of pathways, and has a regulatory role in nematode fat deposition.
Nematode Obesity Model Analysis
Measurement of nematode physiological indices
- Longevity
- Pharyngeal pumping rate
- Number of offspring
- Heat stress resistance
- Athletic ability
- Resistance to oxidative stress
Determination of nematode biochemical indicators
- Lipofuscin
- Enzyme activity
- Reactive oxygen species
- Malondialdehyde (MDA)
- Oil red staining
- Triglyceride (TG)
Special analysis
- Fluorescent protein
- Fat deposition
- mRNA expression
- Fat synthesis pathway
- Metabolites
- Fat catabolic pathway
Workflow
The nematode obesity model construction process usually involves the steps of selecting target nematode species, designing experimental protocols, designing induction protocols, screening and validating the model, and finally performing phenotypic analysis and functional validation.
Applications
- The nematode obesity model can be used to study genetic and environmental factors in obesity and provide a theoretical basis for preclinical studies.
- The nematode obesity model can be used in many research areas to perform rapid, large-scale, high-throughput screening using genetic modifications to discover drugs and bioactive compounds.
- An in-depth study of the metabolic mechanisms of nematode obesity models helps reveal the pathogenesis and treatment of metabolic diseases such as obesity.
- The nematode obesity model can be used to analyze the role of fatty acid synthesis, glycolysis, and other metabolic pathways in obesity, providing a basis for drug development.
Advantages of Us
- Relying on advanced genetics techniques, our researchers provide identification and analysis of obesity-related genes in nematode obesity models.
- Our company supports the integration of nematode obesity models with other biological models to expand their potential in drug screening and metabolic disease research.
- Our researchers have proven experience in genetic engineering experiments to ensure accurate operations.
Unlocking the Molecular Secrets of Obesity with Protheragen
As a leading biotechnology company, we have extensive experience and exceptional expertise in anti-obesity research. Our team is well versed in anti-obesity target discovery, development of reliable therapies, and critical preclinical studies. By choosing us, you will gain a trusted partner. We promise to be your best helper in anti-obesity research with efficient solutions.
|
|
|
|
|
|
|
Publication Data
Technology: Dose-response assessment, Gas chromatography-mass spectrometry (GC-MS)
Journal: Marine Drugs
Published: 2023
IF: 4.9
Results: In this article, researchers used Caenorhabditis elegans as an obesity model to evaluate the anti-obesity effect of Caulerpa lentillifera by measuring the nematode's parameters of body length, body width, and fat droplet size, and combining them with biochemical analyses and gene expression assays. The results showed that the C. lentillifera extracts significantly reduced the body weight and fat accumulation of C. elegans, indicating its anti-obesity effect. C. lentillifera extracts promote fat consumption by increasing the metabolic rate of C. elegans, thus reducing fat accumulation. The gene expression assay revealed that C. lentillifera extracts regulated the fat metabolism process by affecting the expression of genes related to fat metabolism.
Fig.1 Effect of C. lentillifera extracts on the expression level of the dhs-3 gene in C. elegans. (Chumphoochai, et al., 2023)
Frequently Asked Questions
What are the enzymes or proteins involved in the lipolysis pathway in nematodes?
The pathway of fatty acid breakdown in nematodes is similar to that in humans. Enzymes or proteins involved in the lipolysis pathway in nematodes include fatty acid translocase (FAT/CD36), fatty acid transfer protein (FATP), fatty acid binding protein (FABP), acyl-coenzyme A binding protein (ACBP), carnitine-palmitoyltransferases (CPTs), and ATP-binding cassette (ABC) transfer protein.
What are the core pathways involved in the regulation of nematode lipid metabolism?
The core pathways include insulin and transforming growth factor beta (TGFB) signaling pathways, nuclear hormone receptor-mediated signaling pathways, signaling pathways regulated by the transcriptional regulator sterol regulatory element-binding protein, and 5-hydroxytryptamine-mediated signaling pathways.
Protheragen is an industry-leading preclinical anti-obesity therapy research company dedicated to providing our clients with high-quality nematode obesity models. Our experienced research team is your most reliable obesity modeling partner. Please feel free to contact us at your convenience.
Reference
- Chumphoochai, K.; et al. Anti-obesity effects of marine macroalgae extract Caulerpa lentillifera in a Caenorhabditis elegans model. Marine Drugs. 2023, 21(11): 577.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.